Cimino M, Weiss B
Department of Pharmacology, Medical College of Pennsylvania at Eastern Pennsylvania Psychiatric Institute, Philadelphia 19129.
Biochem Pharmacol. 1988 Jul 15;37(14):2739-45. doi: 10.1016/0006-2952(88)90036-6.
To determine the factors that influence the interaction between phenoxybenzamine and calmodulin, the binding of phenoxybenzamine to calmodulin was determined by equilibrium dialysis under a variety of experimental conditions. This interaction was found to be similar in some respects to the interaction between phenothiazines and calmodulin. It was saturable, with between 1 and 2 mol of phenoxybenzamine bound to 1 mol of calmodulin. It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin. However, in contrast to the reversible binding of most phenothiazines to calmodulin, phenoxybenzamine bound to calmodulin irreversibly. The binding of phenoxybenzamine to calmodulin was fairly selective in that other alpha-adrenergic agents such as prazosin, yohimbine and clonidine failed to bind to calmodulin when examined under the same experimental conditions. In addition, phenoxybenzamine showed little or no calcium-dependent binding to the S-100 protein, bovine serum albumin or cytochrome c. The irreversible complex between phenoxybenzamine and calmodulin may be useful for inhibiting certain calmodulin-dependent reactions and for studying the various biological functions of calmodulin.
为了确定影响苯氧苄胺与钙调蛋白相互作用的因素,在各种实验条件下通过平衡透析法测定了苯氧苄胺与钙调蛋白的结合情况。发现这种相互作用在某些方面与吩噻嗪类药物和钙调蛋白之间的相互作用相似。它具有饱和性,1摩尔钙调蛋白可结合1至2摩尔苯氧苄胺。它还取决于温度、二价阳离子(如钙)的存在以及pH值,在pH 6.5时结合力最大,在pH值低于4.2或高于8.0时结合力很小。苯氧苄胺与钙调蛋白结合的位点似乎与某些抗精神病药物结合的位点相似,因为其中几种药物,包括五氟利多、匹莫齐特和螺哌啶,可阻止苯氧苄胺与钙调蛋白的结合。然而,与大多数吩噻嗪类药物与钙调蛋白的可逆结合不同,苯氧苄胺与钙调蛋白的结合是不可逆的。在相同实验条件下检测时,其他α-肾上腺素能药物如哌唑嗪、育亨宾和可乐定未能与钙调蛋白结合,这表明苯氧苄胺与钙调蛋白的结合具有相当的选择性。此外,苯氧苄胺与S-100蛋白、牛血清白蛋白或细胞色素c几乎没有或没有钙依赖性结合。苯氧苄胺与钙调蛋白之间的不可逆复合物可能有助于抑制某些钙调蛋白依赖性反应,并用于研究钙调蛋白的各种生物学功能。